← SynDRA
UNC-0646
SynDRA canonical compound SYN0062942 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EHMT2 |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AURKA
- HDAC6
- SMAD3
- RIPK2
- RIOK2
- HTR6
- HTR2B
- HRH1
- GNAS
- AURKB
- GLP1R
- GAA
- FLT3
- EHMT2
- CXCL8
- AURKC
- TNF
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ACM4
- ACM5
- PA1B2
- RGS4
Cross-references
Synonyms
- UNC0646
- Z5F4D95Y7J
- RefChem:933792
- MFCD22378486
- C36H59N7O2
- orb1296112
- SCHEMBL16569051
- SCHEMBL29384547
- CHEBI:124924
- EX-A2318
- UNC0646?
- BDBM50353131
- HB1423
- AKOS024458104
- NCGC00189144-01
- NCGC00189144-04
- AC-36027
- AS-75236
- HY-13807
- BRD-K87465484-001-02-7
- BRD-K87465484-001-03-5
- N-(1-cyclohexyl-4-piperidinyl)-6-methoxy-7-[3-(1-piperidinyl)propoxy]-2-(4-propan-2-yl-1,4-diazepan-1-yl)-4-quinazolinamine
- N-(1-Cyclohexyl-4-piperidinyl)-2-[hexahydro-4-(1-methylethyl)-1H-1,4-diazepin-1-yl]-6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinamine
Look up UNC-0646 in the interactive SynDRA portal →